These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 24258999)
21. FDG PET in early stage cutaneous malignant melanoma. McIvor J; Siew T; Campbell A; McCarthy M J Med Imaging Radiat Oncol; 2014 Apr; 58(2):149-54; quiz 266. PubMed ID: 24690243 [TBL] [Abstract][Full Text] [Related]
22. Capsule endoscopy versus positron emission tomography for detection of small-bowel metastatic melanoma: a pilot study. Prakoso E; Fulham M; Thompson JF; Selby WS Gastrointest Endosc; 2011 Apr; 73(4):750-6. PubMed ID: 21288518 [TBL] [Abstract][Full Text] [Related]
23. FDG-PET/CT in the evaluation of anal carcinoma. Cotter SE; Grigsby PW; Siegel BA; Dehdashti F; Malyapa RS; Fleshman JW; Birnbaum EH; Wang X; Abbey E; Tan B; Kodner IJ; Hunt SR; Lowney JK; Mutch MG; Dietz DW; Myerson RJ Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):720-5. PubMed ID: 16626889 [TBL] [Abstract][Full Text] [Related]
24. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Clark PB; Soo V; Kraas J; Shen P; Levine EA Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694 [TBL] [Abstract][Full Text] [Related]
34. [Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography/ computed tomography for N-and M-staging of malignant melanoma]. Gu H; Xu W; Song X; Dai D; Zhu L; Wang J Zhonghua Yi Xue Za Zhi; 2014 May; 94(17):1309-12. PubMed ID: 25142850 [TBL] [Abstract][Full Text] [Related]
35. Clinical applications of positron emission tomography-computed tomography in oncology. Kumar R; Halanaik D; Malhotra A Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371 [TBL] [Abstract][Full Text] [Related]
36. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose. Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811 [TBL] [Abstract][Full Text] [Related]
37. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node. Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457 [TBL] [Abstract][Full Text] [Related]
38. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients. Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850 [TBL] [Abstract][Full Text] [Related]
39. Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Steinert HC; Huch Böni RA; Buck A; Böni R; Berthold T; Marincek B; Burg G; von Schulthess GK Radiology; 1995 Jun; 195(3):705-9. PubMed ID: 7753998 [TBL] [Abstract][Full Text] [Related]
40. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma. Kurli M; Chin K; Finger PT Br J Ophthalmol; 2008 Apr; 92(4):479-82. PubMed ID: 18369064 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]